-
Something wrong with this record ?
Lactulose in combination with soybean lecithin has a cryoprotective effect on probiotic taxa of bifidobacteria and Lactobacillaceae
J. Killer, VN. Bunešová, N. Modráčková, E. Vlková, R. Pechar, I. Šplíchal
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Bifidobacterium MeSH
- Glycine max MeSH
- Cryoprotective Agents pharmacology MeSH
- Lactobacillaceae MeSH
- Lactulose * therapeutic use MeSH
- Lecithins MeSH
- Probiotics * therapeutic use MeSH
- Publication type
- Journal Article MeSH
Lactulose is commonly used in pharmacy for constipation and hepatic encephalopathy treatment. The prebiotic effect of lactulose is also often mentioned. However, its cryoprotective effect in combination with lecithin on the main representatives of probiotics has not been tested yet. The 12 taxa of bifidobacteria and Lactobacillaceae members were used for the purpose. These were mixed in a ratio of 1:1 with lactulose + lecithin (finally 5.0% and 1.25%, respectively; LL). The 25% glycerol (G+) solution and cultures themselves were applied as positive and negative controls, respectively. Bacterial suspensions were stored at a mild freezing temperature (-20°C) until the end of the experiment (210th day). The LL solution had a comparable (insignificant difference at the P-value = 0.05) cryoprotective effect as the positive control in five of six bifidobacteria and in three of six representatives of Lactobacillaceae. The better cryoprotective effect was revealed in other Lactobacillaceae. At the end of the experiment, the generally accepted therapeutic minimum (>107 Colony Forming Units/mL) was determined in LL solution in five bifidobacteria and four Lactobacillaceae strains. The presented results improve knowledge about long-term mild cryopreservation of the most commonly used probiotics and could contribute to developing new forms of (nutri)synbiotics.
Food Research Institute Prague Radiová 1285 7 102 00 Prague 10 Hostivař Czech Republic
Institute of Animal Physiology and Genetics of the Czech Academy of Sciences v v i
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004155
- 003
- CZ-PrNML
- 005
- 20250430090455.0
- 007
- ta
- 008
- 230418s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/lambio/ovad008 $2 doi
- 035 __
- $a (PubMed)36657381
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Killer, Jiří $u Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, v. v. i.; Vídeňská 1083, 142 20 Prague 4-Krč, Czech Republic $u Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Kamýcká 129, 165 00 Prague 6-Suchdol, Czech Republic
- 245 10
- $a Lactulose in combination with soybean lecithin has a cryoprotective effect on probiotic taxa of bifidobacteria and Lactobacillaceae / $c J. Killer, VN. Bunešová, N. Modráčková, E. Vlková, R. Pechar, I. Šplíchal
- 520 9_
- $a Lactulose is commonly used in pharmacy for constipation and hepatic encephalopathy treatment. The prebiotic effect of lactulose is also often mentioned. However, its cryoprotective effect in combination with lecithin on the main representatives of probiotics has not been tested yet. The 12 taxa of bifidobacteria and Lactobacillaceae members were used for the purpose. These were mixed in a ratio of 1:1 with lactulose + lecithin (finally 5.0% and 1.25%, respectively; LL). The 25% glycerol (G+) solution and cultures themselves were applied as positive and negative controls, respectively. Bacterial suspensions were stored at a mild freezing temperature (-20°C) until the end of the experiment (210th day). The LL solution had a comparable (insignificant difference at the P-value = 0.05) cryoprotective effect as the positive control in five of six bifidobacteria and in three of six representatives of Lactobacillaceae. The better cryoprotective effect was revealed in other Lactobacillaceae. At the end of the experiment, the generally accepted therapeutic minimum (>107 Colony Forming Units/mL) was determined in LL solution in five bifidobacteria and four Lactobacillaceae strains. The presented results improve knowledge about long-term mild cryopreservation of the most commonly used probiotics and could contribute to developing new forms of (nutri)synbiotics.
- 650 12
- $a laktulosa $x terapeutické užití $7 D007792
- 650 _2
- $a kryoprotektivní látky $x farmakologie $7 D003451
- 650 _2
- $a lecitiny $7 D054709
- 650 _2
- $a Glycine max $7 D013025
- 650 _2
- $a Lactobacillaceae $7 D007777
- 650 _2
- $a Bifidobacterium $7 D001644
- 650 12
- $a probiotika $x terapeutické užití $7 D019936
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bunešová, Věra Neužil $u Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Kamýcká 129, 165 00 Prague 6-Suchdol, Czech Republic
- 700 1_
- $a Modráčková, Nikol $u Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Kamýcká 129, 165 00 Prague 6-Suchdol, Czech Republic
- 700 1_
- $a Vlková, Eva, $d 1977- $u Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Kamýcká 129, 165 00 Prague 6-Suchdol, Czech Republic $1 https://orcid.org/0000000332192003 $7 xx0035179
- 700 1_
- $a Pechar, Radko $u Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Kamýcká 129, 165 00 Prague 6-Suchdol, Czech Republic $u Food Research Institute Prague, Radiová 1285/7, 102 00 Prague 10-Hostivař, Czech Republic
- 700 1_
- $a Šplíchal, Igor $u Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, 549 22 Nový Hrádek, Czech Republic
- 773 0_
- $w MED00003137 $t Letters in applied microbiology $x 1472-765X $g Roč. 76, č. 2 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36657381 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20250430090450 $b ABA008
- 999 __
- $a ok $b bmc $g 1924676 $s 1190364
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 76 $c 2 $e 2023Feb16 $i 1472-765X $m Letters in applied microbiology $n Lett Appl Microbiol $x MED00003137
- LZP __
- $a Pubmed-20230418